Patent · US Active

Bifidobacterium longum NCIMB 41676

US10813366B2 · kind B2 · utility

2Cited by

1References

25Claims

0Family size

Assignees

PrecisionBiotics Group Limited · IE
UNIVERSITY COLLEGE CORK—NATIONAL UNIVERSITY OF IRELAND, Cork · IE

Inventors

Eileen Frances Murphy · Cork, IE
David GROEGER · Cork, IE
Timothy Dinan · Dublin, IE
John Cryan · Cork, IE

Key dates

Filing date	Feb 18, 2020
Grant date	Oct 27, 2020
Priority date	—
Expiry date	Feb 18, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/01
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of treating a subject by administering Bifidobacterium longum strain NCIMB 41676 are discussed. The method may include orally administering a formulation comprising Bifidobacterium longum strain NCIMB 41676 to improve sleep.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.